| __timestamp | Arrowhead Pharmaceuticals, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 3401685 |
| Thursday, January 1, 2015 | 57410147 | 4284228 |
| Friday, January 1, 2016 | 41454452 | 3581295 |
| Sunday, January 1, 2017 | 31690298 | 4838300 |
| Monday, January 1, 2018 | 52968505 | 24891534 |
| Tuesday, January 1, 2019 | 81048686 | 31347891 |
| Wednesday, January 1, 2020 | 128874979 | 17480747 |
| Friday, January 1, 2021 | 206342000 | 34710152 |
| Saturday, January 1, 2022 | 297307000 | 108459978 |
| Sunday, January 1, 2023 | 353188000 | 181563523 |
| Monday, January 1, 2024 | 505870000 | 176326321 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Arrowhead Pharmaceuticals, Inc. has consistently outpaced Opthea Limited in R&D investments. Starting in 2014, Arrowhead's R&D expenses were nearly seven times higher than Opthea's, and this gap has only widened. By 2023, Arrowhead's R&D spending surged to over 350% of its 2014 levels, while Opthea's increased by approximately 530% during the same period. This trend highlights Arrowhead's aggressive investment strategy, positioning it as a leader in the biotech sector. Meanwhile, Opthea's steady growth in R&D spending reflects its commitment to innovation, albeit on a smaller scale. As we look to the future, these spending patterns may offer insights into each company's potential breakthroughs and market positioning.
Johnson & Johnson or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Incyte Corporation and Opthea Limited
R&D Spending Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. vs Opthea Limited: Strategic Focus on R&D Spending
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and CRISPR Therapeutics AG
Opthea Limited vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Geron Corporation
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.